Why Open AI CEO Sal Altman Delays GPT-5 Training

Date:

The CEO of OpenAI, Sam Altman, recently confirmed that GPT-5 won’t undergo training yet. According to Altman, the AI model will require a lot of work before training can even begin, which could take several months. Altman’s announcement came as a surprise to some people who were anticipating GPT-5’s release shortly after the launch of GPT-4. Industry experts have previously pointed out the limitations of AI and questioned its safety for human use. In March, tech industry giants like Steve Wozniak and Elon Musk signed a letter opposing AI development and called for a temporary halt in AI labs’ operations for six months. Although Altman acknowledged the concerns about the dangers of AI, he believes that shutting down smaller AI startups is a bad idea. Altman encourages lawmakers to engage in a big discussion about AI and said that OpenAI is willing to work with regulators for successful AI implementations. The expected features for GPT-5 include reduced hallucinations, bigger computing power, multimodal functionality, and long-term memory. The AI model’s debut may happen in 2024.

See also  The Future of AI and Employment: Managerial Choices and The Power of Augmentation

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.